Molenaar P, Bartel S, Cochrane A, Vetter D, Jalali H, Pohlner P, Burrell K, Karczewski P, Krause E G, Kaumann A
Department of Medicine, The Prince Charles Hospital, University of Queensland, Australia.
Circulation. 2000 Oct 10;102(15):1814-21. doi: 10.1161/01.cir.102.15.1814.
In adult human heart, both beta(1)- and beta(2)-adrenergic receptors mediate hastening of relaxation; however, it is unknown whether this also occurs in infant heart. We compared the effects of stimulation of beta(1)- and beta(2)-adrenergic receptors on relaxation and phosphorylation of phospholamban and troponin I in ventricle obtained from infants with tetralogy of Fallot.
Myocardium dissected from the right ventricular outflow tract of 27 infants (age range 21/2 to 35 months) with tetralogy of Fallot was set up to contract 60 times per minute. Selective stimulation of beta(1)-adrenergic receptors with (-)-norepinephrine (NE) and beta(2)-adrenergic receptors with (-)-epinephrine (EPI) evoked phosphorylation of phospholamban (at serine-16 and threonine-17) and troponin I and caused concentration-dependent increases in contractile force (-log EC(50) [mol/L] NE 5.5+/-0.1, n=12; EPI 5.6+/-0.1, n=13 patients), hastening of the time to reach peak force (-log EC(50) [mol/L] NE 5.8+/-0.2; EPI 5.8+/-0.2) and 50% relaxation (-log EC(50) [mol/L] NE 5.7+/-0.2; EPI 5.8+/-0.1). Ventricular membranes from Fallot infants, labeled with (-)-[(125)I]-cyanopindolol, revealed a greater percentage of beta(1)- (71%) than beta(2)-adrenergic receptors (29%). Binding of (-)-epinephrine to beta(2)-receptors underwent greater GTP shifts than binding of (-)-norepinephrine to beta(1)-receptors.
Despite their low density, beta(2)-adrenergic receptors are nearly as effective as beta(1)-adrenergic receptors of infant Fallot ventricle in enhancing contraction, relaxation, and phosphorylation of phospholamban and troponin I, consistent with selective coupling to G(s)-protein.
在成年人心脏中,β₁-和β₂-肾上腺素能受体均可介导舒张加速;然而,在婴儿心脏中是否也如此尚不清楚。我们比较了刺激β₁-和β₂-肾上腺素能受体对法洛四联症婴儿心室中受磷蛋白和肌钙蛋白I的舒张及磷酸化的影响。
从27例年龄在2.5至35个月的法洛四联症婴儿的右心室流出道切取心肌,使其每分钟收缩60次。用(-)-去甲肾上腺素(NE)选择性刺激β₁-肾上腺素能受体,用(-)-肾上腺素(EPI)刺激β₂-肾上腺素能受体,可诱发受磷蛋白(丝氨酸-16和苏氨酸-17位点)和肌钙蛋白I的磷酸化,并导致收缩力呈浓度依赖性增加(-log EC₅₀[mol/L],NE为5.5±0.1,n = 12;EPI为5.6±0.1,n = 13例患者),达到峰值力的时间加速(-log EC₅₀[mol/L],NE为5.8±0.2;EPI为5.8±0.2)以及50%舒张时间加速(-log EC₅₀[mol/L],NE为5.7±0.2;EPI为5.8±0.1)。用(-)-[¹²⁵I]-氰吲哚洛尔标记的法洛四联症婴儿心室膜显示,β₁-肾上腺素能受体的比例(71%)高于β₂-肾上腺素能受体(29%)。(-)-肾上腺素与β₂-受体的结合比(-)-去甲肾上腺素与β₁-受体的结合经历更大的GTP位移。
尽管β₂-肾上腺素能受体密度较低,但在增强法洛四联症婴儿心室的收缩、舒张以及受磷蛋白和肌钙蛋白I的磷酸化方面,其效果与β₁-肾上腺素能受体相近,这与选择性偶联至Gₛ蛋白一致。